Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease

Respir Med. 2006 Apr;100(4):630-8. doi: 10.1016/j.rmed.2005.08.009. Epub 2005 Oct 6.


Chronic obstructive pulmonary disease (COPD) patients have increased neutrophils and macrophages in their lungs, and inflammation of the airway is related to oxidative stress. This study assessed the levels of 8-isoprostane (an oxidative stress marker) and chemokines related to neutrophil and monocyte inflammation (growth-related oncogene alpha [GROalpha] and monocyte chemoattractant protein-1 [MCP-1]) in the airway of ex-smoking COPD patients by exhaled breath condensate (EBC) collection. Thirty-two (28 males) stable COPD patients (14 with FEV(1) 50% [Group 1], 18 with FEV(1) <50% predicted [Group 2]) and 18 non-smoking age and sex-matched controls were studied in this cross-sectional study. EBC was collected using the EcoScreen (Jaeger, Germany) during 10 min of tidal breathing with the nose clipped. Concentrations of 8-isoprostane, GROalpha and MCP-1 were measured by enzyme immunoassays. COPD patients had a higher concentration of 8-isoprostane than controls (COPD versus control, P<0.001; Group 1 versus Group 2, P=0.045). 8-isoprostane increased across the groups from normal, Group 1 to Group 2 (r=0.64, P<0.001). The median intraquartile range (IQR) levels in pg/ml for GROalpha were 45.3(44.5-46.5), 45.4(44.5-46.0), 46.0(45.6-47.3), whereas MCP-1 levels were 5.3(5.2-5.9), 6.2(5.4-6.9) and 5.7(5.5-6.4) in Group 1, Group 2 COPD and control subjects, respectively. GROalpha level was lower in COPD patients when compared to controls (P=0.01). MCP-1 level did not differ between COPD and the control group. 8-isoprostane level, but not GROalpha and MCP-1, in EBC was increased in COPD patients with poorer lung function. This suggests an increased oxidative stress in the airway in patients with more severe COPD.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / analysis
  • Breath Tests* / methods
  • Chemokine CCL2 / analysis*
  • Chemokine CXCL1
  • Chemokines, CXC / analysis*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / analysis*
  • Male
  • Middle Aged
  • Oncogenes
  • Oxidative Stress / physiology*
  • Prospective Studies
  • Prostaglandins A / analysis*
  • Pulmonary Disease, Chronic Obstructive / diagnosis*
  • Pulmonary Disease, Chronic Obstructive / physiopathology


  • 8-isoprostaglandin A2
  • Biomarkers
  • CXCL1 protein, human
  • Chemokine CCL2
  • Chemokine CXCL1
  • Chemokines, CXC
  • Intercellular Signaling Peptides and Proteins
  • Prostaglandins A